Cargando…

Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months

In this correspondence we discuss the results of the meta-analysis by De Luca et al. (2012) in the Archives of Internal Medicine which found that late myocardial reinfarction and stent thrombosis is more common in drug-eluting stents than in bare-metal stents. We discuss the clinical implications of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohasseb, Iman, Gericke, Christian A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2012
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799550/ https://www.ncbi.nlm.nih.gov/pubmed/24358835 http://dx.doi.org/10.12688/f1000research.1-53.v1

Ejemplares similares

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Angioscopic imaging one month after the implantation of a drug-eluting stent following drug-coated balloon treatment
por: Sone, Hiromoto, et al.
Publicado: (2018)

Dural Venous Sinus Angioplasty and Stenting for Treatment of Idiopathic Intracranial Hypertension
por: Qiu, Min-Jian, et al.
Publicado: (2017)

Reviving Intracranial Angioplasty and Stenting “SAMMPRIS and beyond”
por: Farooq, Muhammad U., et al.
Publicado: (2014)

A Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary Stents
por: Yang, Jian, et al.
Publicado: (2015)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Abdelmegid, Mohamed Aboel-Kassem F., et al.
Publicado: (2017)

One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
por: Natsuaki, Masahiro, et al.
Publicado: (2015)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Stent infection after carotid angioplasty – Treatment with dual layer stent
por: Manzato, Luciano B., et al.
Publicado: (2020)

Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression
por: Villablanca, Pedro A., et al.
Publicado: (2016)

Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting Stents: A Meta-Analysis
por: Loomba, Rohit S., et al.
Publicado: (2011)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
por: Kim, Minsu, et al.
Publicado: (2023)

Cutting-balloon angioplasty before drug-eluting stent implantation for the treatment of severely calcified coronary lesions
por: Tang, Zhe, et al.
Publicado: (2014)

Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial
por: Spreen, Marlon I., et al.
Publicado: (2016)

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
por: Kim, J-S, et al.
Publicado: (2009)

One-year clinical outcomes of different coronary drug eluting stents—Data from a prospective registry
por: Sastry, B.K.S., et al.
Publicado: (2018)

Surgical management of a left anterior descending Coronary Artery Aneurysm after drug eluting stent implantation
por: Koza, Yavuzer, et al.
Publicado: (2021)

Spontaneous Huge Subdural Spine Hematoma in a Patient Receiving Dual Anti-platelet Therapy after Drug-eluting Coronary Stent Implantation
por: Han, Xiongyi, et al.
Publicado: (2018)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Zhu, Yong, et al.
Publicado: (2021)

The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI Segment
por: Tacke, Josef, et al.
Publicado: (2019)

Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis
por: Wu, Haokun, et al.
Publicado: (2022)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries
por: van Overhagen, Hans, et al.
Publicado: (2023)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Late primary angioplasty (beyond 12 h): are we sure it should be avoided?
por: Bolognese, Leonardo
Publicado: (2021)

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
por: Kook, Hyungdon, et al.
Publicado: (2020)

12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry
por: Ho, Hee Hwa, et al.
Publicado: (2020)

Analysis of Potential Cost-Savings After Introduction of Drug-Eluting Balloon Angioplasty for In-Stent Restenosis or Small Vessel Disease
por: Park, Kyungil, et al.
Publicado: (2011)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Carotid Artery Stent Continued Expansion Days After Deployment, Without Post Stent Deployment Angioplasty
por: Qazi, Umair, et al.
Publicado: (2015)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
por: Pivato, Carlo A., et al.
Publicado: (2022)

Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
por: Suzuki, Satoshi, et al.
Publicado: (2019)

Angioplasty and Stenting for Intracranial Stenosis
por: IZUMI, Takashi, et al.
Publicado: (2014)

It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent
por: Kim, Ju-Youn, et al.
Publicado: (2015)

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial
por: Kedhi, Elvin, et al.
Publicado: (2018)

Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study
por: Dadjou, Yahya, et al.
Publicado: (2016)

Dual antiplatelet therapy and drug eluting stents: a marriage of convenience
por: Benezet-Mazuecos, Juan, et al.
Publicado: (2007)

Estrogen-Eluting Stents
por: Ryu, Sung Kee, et al.
Publicado: (2009)

Vascular Responses to First-Generation Sirolimus-Eluting Stents and Bare-Metal Stents Beyond 10 Years
por: Hada, Masahiro, et al.
Publicado: (2021)

Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis
por: Choi, Hong Sang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_is59qsvov552famv9e8ob4n9h7